BS 100 141,
BS-100-141,
BS100141,
Estulic,
Guanfacine,
Guanfacine Hydrochloride,
Guanfacine Monohydrochloride,
Hydrochloride, Guanfacine,
Lon798,
Monohydrochloride, Guanfacine,
Tenex,
guanfacine hydrochloride,
29110-48-3,
GUANFACINE HCL,
Tenex,
Estulic,
Intuniv,
N-Carbamimidoyl-2-(2,6-dichlorophenyl)acetamide hydrochloride,
Guanfacin hydrochloride,
29520-14-7,
Guanfacine (hydrochloride),
BS 100-141,
N-Amidino-2-(2,6-dichlorophenyl)acetamide hydrochloride,
N-(Aminoiminomethyl)-2,6-dichlorobenzeneacetamide hydrochloride,
LON 798,
MLS000069745,
N-Amidino-2-(2,6-dichlorophenyl)acetamide monohydrochloride,
BS-100-141,
N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide hydrochloride,
UNII-PML56A160O,
SMR000058453,
SPD 503,
EINECS 249-443-3,
DSSTox_CID_25157,
DSSTox_RID_80708,
DSSTox_GSID_45157,
N (Aminoiminomethyl)-2,6-dichlorobenzeneacetamide,
[(2,6-Dichlorophenyl)acetyl]guanidine Hydrochloride,
N-(Aminoiminomethyl)-2,6-dichlorophenylacetamide monohydrochloride,
Benzeneacetamide, N-(aminoiminomethyl)-2,6-dichloro-, monohydrochloride,
Connexyn,
PML56A160O,
CAS-29520-14-7,
Tenex (TN),
MFCD00798230,
SR-01000075893,
NCGC00015469-05,
Guanfacine hydrochloride [USAN:JAN],
Guanfacin,
SPD-503,
Prestwick_740,
Guanfacine hydrochloride (JAN/USP),
Intuniv (TN),
GuanfacineHydrochloride,
n-carbamimidoyl-2-(2,6-dichlorphenyl)acetamidhydrochlorid,
Guarfacine Hydrochloride,
Guanfascine Hydrochloride,
C9H9Cl2N3O.HCl,
Opera_ID_1928,
G 1043,
AC1L2G3E,
C9H10Cl3N3O,
SCHEMBL41681,
MLS001077329,
MLS002222252,
AC1Q3P39,
CHEBI:5559,
CHEMBL1200494,
DTXSID2045157,
SCHEMBL15603414,
CTK8C3871,
CTK8G0106,
HMS1569C19,
Pharmakon1600-01505435,
BCP21710,
KS-000017QB,
N-(aminoiminomethyl)-2,6-dichloro-benzeneacetamide hydrochloride,
Tox21_110159,
Tox21_500519,
ANW-70740,
BG0397,
NSC759121,
s4693,
AKOS015966858,
Tox21_110159_1,
API0006740,
CCG-213439,
CCG-220339,
LP00519,
NSC-759121,
NCGC00015469-09,
NCGC00093914-01,
NCGC00093914-02,
NCGC00180965-01,
NCGC00261204-01,
AS-12253,
BC202678,
LS-28474,
Guanfacine hydrochloride, >=98% (HPLC),
AB0011596,
AX8239284,
TC-159485,
EU-0100519,
FT-0630546,
FT-0698181,
G0414,
D00606,
W-5123,
A826918,
J-017395,
S-877503,
SR-01000075893-1,
SR-01000075893-3,
SR-01000075893-6,
Guanfacine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material,
Guanfacine hydrochloride, United States Pharmacopeia (USP) Reference Standard,
N-[bis(azanyl)methylidene]-2-[2,6-bis(chloranyl)phenyl]ethanamide hydrochloride,
GUANFACINE,
GUANFACINEHCL,
C9H9Cl2N3O.ClH,
D0WD8M,
SPD503,
C9-H9-Cl2-N3-O.Cl-H,
CID71401,
AR-1K6511,
ACN-048730,
Guanfacine hydrochloride [USAN:USP:JAN],
Guanfacine hydrochloride, 98% - 100MG 100mg,
29110-47-2,
458-92-4,
Benzeneacetamide, N-(aminoiminomethyl)-2,6-dichloro-, hydrochloride (1:1),